Every Form 4 that Aterian, Inc. (ATER) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ATER and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ATER filings page.
Aterian, Inc. (ATER) reported that Chief Executive Officer and ten percent owner David E. Lazar made several preferred-stock transactions. On July 17, 2026, he acquired 1,750,000 Series AAA Convertible Non-Redeemable Preferred Shares at $2.00 per share, for an aggregate $3,500,000, under an April 27, 2026 Securities Purchase Agreement; each share is convertible, after required stockholder approvals, into 135.1 shares of common stock (up to 236,425,000 common shares) at a conversion price of $0.0148 with no additional consideration and no expiration. Following stockholder approval, on August 4, 2026 he converted Series AA Convertible Non-Redeemable Preferred Stock into 6,737,500 shares of common stock and held 6,737,500 common shares directly afterward. The filing states that these transactions were not made under a Rule 10b5-1 trading plan.
Rodriguez Arturo reported acquisition or exercise transactions in this Form 4 filing.
Aterian, Inc. Chief Executive Officer Arturo Rodriguez received a grant of 70,000 shares of restricted common stock at $0.00 per share. The award was granted under the company’s 2018 Equity Incentive Plan, is subject to vesting, and was approved by the Compensation Committee for retention purposes. Following this grant, Rodriguez directly holds 1,081,148 shares of common stock.
Aterian, Inc. director David E. Lazar entered into a Securities Purchase Agreement to acquire preferred equity in the company. On April 27, 2026, he purchased 1,750,000 shares of Series AA Convertible Non-Redeemable Preferred Stock at $2.00 per share, for a total of $3,500,000, and currently holds no beneficially owned common stock.
The agreement also provides that, at a subsequent closing following required stockholder approvals, he will acquire an additional 1,750,000 Series AAA Convertible Non-Redeemable Preferred Shares at $2.00 per share, for another $3,500,000. After stockholder approvals and a charter amendment, each Series AA share will be convertible into 7.7 common shares, while each Series AAA share will convert into between 117.63 and 135.10 common shares, at the holder’s option for no additional consideration.
Aterian, Inc. director William Kurtz received an equity award of 40,394 shares of common stock on January 23, 2026. The shares are restricted stock granted under Aterian’s 2018 Equity Incentive Plan and are subject to vesting, and the award was made in lieu of cash compensation for his service on the Board of Directors. The shares were acquired at a stated price of $0 per share, bringing his directly held beneficial ownership to 155,922 shares of Aterian common stock.
Aterian, Inc. reported that its Chief Financial Officer, Joshua O. Feldman, received an award of 120,000 shares of common stock on 01/23/2026. These shares are described as restricted stock granted under the company’s 2018 Equity Incentive Plan and are subject to vesting conditions. The filing notes that this award was made outside Aterian’s regular annual equity grant cycle and was approved by the Compensation Committee for retention purposes. Following this grant, Feldman beneficially owns 497,442 shares of Aterian common stock in direct ownership.
Aterian, Inc. reported that its Chief Executive Officer and director, Arturo Rodriguez, received an award of 50,000 shares of common stock on January 23, 2026. The filing shows these shares were acquired at a price of $0 per share, reflecting a grant rather than an open‑market purchase. After this award, Rodriguez beneficially owned 1,011,148 shares of Aterian common stock in total.
The grant consists of restricted common stock issued under Aterian’s 2018 Equity Incentive Plan and is subject to vesting conditions. According to the disclosure, the award was granted outside the company’s regular annual equity grant cycle and was approved by the Compensation Committee for retention purposes, indicating it is designed to help keep the CEO in his role over time.
Aterian, Inc. director equity grant reported
Aterian, Inc. director Susan E. Lattmann reported receiving 25,555 shares of common stock on 01/23/2026 at a stated price of $0 per share. These shares are restricted stock granted under Aterian’s 2018 Equity Incentive Plan and are subject to vesting. The award was provided in lieu of cash compensation for her service on the Board of Directors. Following this grant, she beneficially owns 162,465 shares of Aterian common stock in direct ownership.
Aterian, Inc. director Bari A. Harlam reported receiving an equity grant of 24,731 shares of common stock on January 23, 2026. The shares are described as restricted common stock granted under Aterian’s 2018 Equity Incentive Plan and are subject to vesting. The award was granted in lieu of cash compensation for Harlam’s service on the Board of Directors and was recorded at a price of $0 per share as a stock-based compensation grant rather than an open-market purchase. Following this grant, Harlam directly beneficially owned 161,991 shares of Aterian common stock.